Price $32.90 |
Market Cap
673.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.74
|
P/S
81.59
|
Dividend %
-
|
|
P/CF
4.4
|
P/FCF
-
|
Op. Cash Flow
-101K
|
FCF
-
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-72.30%
|
ROI
-
|
|
ROA
-44.70%
|
EPS Growth
-35.70%
|
Current Ratio
10.4
|
Debt/Equity
5.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Boston Scientific Corporation (BSX) | $40.88 | - | - | 54.9B | Strong Buy |
| Regulus Therapeutics Inc (RGLS) | $1.23 | - | - | 113.1M | Strong Buy |
| ImmuCell Corporation (ICCC) | $8.50 | - | - | 69.5M | Strong Buy |
| RadNet Inc. (RDNT) | $22.24 | - | - | 1.14B | Strong Buy |
| Aravive Inc (ARAV) | $5.19 | - | - | 129.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
